摘要
目的观察优泌乐50与优泌乐25治疗糖尿病降低餐后血糖水平的临床效果。方法选取63例糖尿病患者,随机分为实验组(32例)和对照组(31例)。两组患者均予以常规饮食治疗和健康教育,在此基础上观察组给予优泌乐50餐前皮下注射,对照组给予优泌乐25餐前皮下注射,连续1周记录两组患者注射优泌乐后餐后血糖的变化情况,分析比较优泌乐50与优泌乐25降低餐后血糖的临床效果。结果两组患者治疗1周后的空腹血糖水平均降低,但差异无统计学意义(P>0.05),治疗后两组患者的日常三餐的餐后2 h血糖水平也均降低,观察组患者餐后血糖水平明显低于对照组,差异具有统计学意义(P<0.05)。结论优泌乐50降低餐后血糖水平的效果明显较优泌乐25优越。
Objective To observe clinical effect of Humalog 50 and Humalog 25 for treating diabetes mellitus and regulating postprandial blood glucose. Methods A total of 63 diabetes mellitus patients were randomly divided into experimental group（32 cases） and control group（31 cases）. Both groups received conventional dietary therapy and health education. The observation group received additional Humalog 50 by preprandial subcutaneous injection, and the control group received Humalog 25 by preprandial subcutaneous injection. Changes of postprandial blood glucose after injection of Humalog were recorded for 1 week in the two groups. Results Both groups had decreased fasting blood glucose after 1 week of treatment, but their difference had no statistical significance（P〉0.05）. They also had decreased 2 h postprandial blood glucose after daily meals. The observation group had much lower level of postprandial blood glucose than the control group, and their difference had statistical significance（P〈0.05）. Conclusion Humalog 50 provides remarkably better effect in regulating postprandial blood glucose than Humalog 25.
出处
《中国实用医药》
2015年第22期28-30,共3页
China Practical Medicine
关键词
糖尿病
优泌乐50
优泌乐25
餐后血糖
Diabetes mellitus
Humalog 50
Humalog 25
Postprandial blood glucose
